Document is current
Any future updates will be listed below
-
Authors
Nakamoto, Shogo https://orcid.org/0000-0001-8043-8608
Ikeda, Masahiko
Kubo, Shinichiro
Yamamoto, Mari
Yamashita, Tetsumasa
Notsu, Akifumi
- License Information
-
More Information
Article History
Received: 24 October 2020
Accepted: 2 March 2021
First Online: 18 March 2021
Competing interests
: Dr. Nakamoto reports having received personal fees from Chugai Pharmaceuticals, Eisai, and Taiho Pharmaceuticals outside of the submitted work; Dr. Ikeda reports having received personal fees from AstraZeneca, Chugai Pharmaceuticals, Daiichi-Sankyo, Eisai, Eli-Lilly, Kyowa Kirin, Pfizer, Nippon Kayaku, Novartis, Mundipharma, Celltrion Healthcare, and Sawai Pharmaceuticals outside of the submitted work; Dr. Kubo has received lecture fees from Eli-Lilly outside of the submitted work; Dr. Yamamoto has received lecture fees from Bayer outside of the submitted work. The other authors have no conflicts of interest.
